ARTV Appoints Diego Miralles as President and Head of R&D, Fred Aslan as Principal Financial Officer, CFO Thad Huston to Depart with $135,000 Severance
Artiva Biotherapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $7.93
-8.3% in 1d after detection
Post-detection moves
1h
—
1d
-8.3%
3d
-8.0%
7d
-7.3%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS